Gyre Therapeutics (GYRE)
A majority-owned Beijing unit sells China's pirfenidone lung-fibrosis therapy while San Diego runs the antifibrotic pipeline.
$7.34
vs last close−0.15 (−2.00%)
Something off on this page? Send us feedback.
Dividend yield
—
Next ex-date
—
Annual dividend
—
Schedule
—
Per share, Sep 2022 to Jan 2023DividendAnnual yield
——————Sep '22Jan '23
Dividend——————$21.45$3.60
Annual yield——————286.00%642.31%
Ex-date——————Sep 21Jan 13
Payment date————————
2 payments since Sep 2022
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jan 13, 2023 | Jan 5, 2023 | $0.24 | cut from $1.43 | |
| Sep 21, 2022 | Sep 6, 2022 | $1.43 |